Skip to Main Content
Beta test
our new site.
(
NLM Technical Bulletin
)
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Cediranib Maleate and Combination Chemotherapy in Treating Patients With Advanced Biliary Cancers
This study has suspended participant recruitment.
( Lack of Drug Supply )
Study NCT01229111 Information provided by National Cancer Institute (NCI)
First Received on October 26, 2010. Last Updated on January 28, 2013
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Advanced Adult Primary Liver Cancer
Periampullary Adenocarcinoma
Recurrent Gallbladder Cancer
Unresectable Gallbladder Cancer
Additional conditions recognized in this trial
Adenocarcinoma
Adenocarcinoma, Mucinous
Bile Duct Neoplasms
Carcinoma
Cholangiocarcinoma
Gallbladder Neoplasms
Liver Neoplasms
More general conditions related to this trial
Bile Duct Diseases
Biliary Tract Diseases
Biliary Tract Neoplasms
Digestive System Diseases
Digestive System Neoplasms
Gallbladder Diseases
Liver Diseases
Neoplasms
Neoplasms by Histologic Type
Neoplasms by Site
Neoplasms, Cystic, Mucinous, and Serous
Neoplasms, Glandular and Epithelial
Interventions listed in this trial
cediranib maleate
oxaliplatin
leucovorin calcium
fluorouracil
Additional drug interventions recognized in this trial
Leucovorin
Levoleucovorin
Maleic acid
More general drug interventions related to this trial
Antidotes
Antimetabolites
Antimetabolites, Antineoplastic
Antineoplastic Agents
Enzyme Inhibitors
Growth Substances
Immunologic Factors
Immunosuppressive Agents
Micronutrients
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Physiological Effects of Drugs
Protective Agents
Therapeutic Uses
Vitamin B Complex
Vitamins
Sponsors listed in this trial
National Cancer Institute (NCI)
Back to top of Main Content
